Sequential protocol with urinary-FSH/recombinant-FSH versus standard protocol with recombinant-FSH in women of advanced age undergoing IVF

Gynecological Endocrinology

Volumn 30, Issue 10, 2014, Pages 730-733

  Colacurci, Nicola ^a   Caprio, Francesca ^a   La Verde, Eugenio ^a   Trotta, Carlo ^a   Ianniello, Raffaele ^a   Mele, Daniela ^a   De Franciscis, Pasquale ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Advanced reproductive age; ART; FSH; Infertility; Oocyte quality

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG; URINARY FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OOCYTE RETRIEVAL; OVARY FOLLICLE MATURATION; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; RETROSPECTIVE STUDY; CLINICAL PROTOCOL; DRUG EFFECTS; OOCYTE; PROCEDURES; STANDARDS; TREATMENT OUTCOME;

ADULT; CLINICAL PROTOCOLS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; OOCYTES; TREATMENT OUTCOME;

EID: 84907915229     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.927856     Document Type: Article

References (21)

1. West CR, Carlson NE, Lee JS, et al. Acidic mix of FSH isoforms are better facilitators of ovarian follicular maturation and E2 production than the less acidic. Endocrinology 2002;143:107-16.
2. Baird DT. Folliculogenesis and gonadotrophins. In: Adashi EY, Baird DT, Crosignani PG, eds. Gonadotrophins and fertility in women. Rome: Serono Fertility Series; 1999: 1-10.
3. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000;21:200-14.
4. Wide L, Bakos O. More basic forms of both human folliclestimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular and luteal phase. J Clin Endocrinol Metab 1993;76:885-9.
5. Ulloa-Aguirre A, Damian-Matsumura P, Jimenez M, et al. Biological characterization of the isoforms of urinary human follicle-stimulating hormone contained in a purified commercial preparation. Hum Reprod 1992;7:1371-8.
6. Wide L, Wide M. Higher plasma disappearance rate in the mouse for pituitary follicle-stimulating hormone of young women compared to that of men and elderly women. J Clin Endocrinol Metab 1984;58: 426-9.
7. D'Antonio M, Borrelli F, Datola A, et al. Biological characterization of recombinant human follicle stimulating hormone isoforms. Hum Reprod 1999;14:1160-7.
8. Bergh C, Howles CM, Borg K, et al. Recombinant human folliclestimulating hormone (r-hFSH;Gonal F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133-9.
9. Out HJ, Driessen SG, Mannaerts BM, Coelingh Bennink HJ. Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertil Steril 1997;68:138-42.
10. Strehler E, Abt M, El-Danasouri I, et al. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome. Fertil Steril 2001; 75:332-6.
11. Hugues JN, Bry-Gauillard H, Bständig B, et al. Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer. J Ass Reprod Genet 2001;18: 191-6.
12. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle-stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534-40.
13. Mohamed MA, Sbracia M, Pacchiarotti A, et al. Urinary folliclestimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study. Fertil Steril 2006; 85:1398-403.
14. Pacchiarotti A, Aragona C, Gaglione R, Selman H. Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle. J Assist Reprod Genet 2007;24:400-5.
15. Daya S, Gunby J. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod 1999;14:2207-15.
16. Wide L. Follicle-stimulating hormones in anterior pituitary gland from children and adults differ in relation to sex and age. J Endocrinol 1989;123:519-29.
17. Selman H, Pacchiarotti A, El-Danasouri I. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome. Fertil Steril 2010;94:1782-6.
18. Selman HA, De Santo M, Sterzik K, et al. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality. Fertil Steril 2002;78:1061-7.
19. Devroey P, Tjandraprawira K, Mannaerts B, et al. A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization. Hum Reprod 1995;10:332-7.
20. Devroey P, van Steirteghem A. A review of ten years experience of ICSI. Hum Reprod Update 2004;10:19-28.
21. Nayudu PL, Vitt UA, Barrios De Tomasi J, et al. Intact follicle culture: what it can tell us about the roles of FSH glycoforms during follicle development. Reprod Biomed Online 2002;5:240-53.